par Raicevic, Gordana ;Najar, Mehdi ;Najimi, Mustapha;El Taghdouini, Adil;van Grunsven, Leo A;Sokal, Etienne M;Toungouz Nevessignsky, Michel
Référence Cytotherapy, 17, 2, page (174-185)
Publication Publié, 2015-02
Référence Cytotherapy, 17, 2, page (174-185)
Publication Publié, 2015-02
Article révisé par les pairs
Résumé : | Stem cell therapy for liver diseases has recently emerged as a promising alternative to liver transplantation. Eligible cells should have an appropriate immunophenotype. The aim of the present study was to define the immunological profile of two human liver-derived mesenchymal stromal cell populations, namely, stem cells (ADHLSC) and hepatic stellate cells (HSC). |